By Christi Guerrini, Alex Pearlman,
and Patti Zettler Jan. 26, 2021Reprints
Jacquelyn Martin/AP
Support for open science accessible, collaborative, and radically transparent research done outside of traditional science venues has been growing. During the Covid-19 pandemic, you might even say it is having a moment.
Networks of amateur and professional researchers around the world have emerged to help develop and disseminate solutions for preventing Covid-19 and gathering data relevant to managing the disease.
As these efforts begin to achieve milestones and mature possibly spinning off into small companies some are certain to attract the attention of the Food and Drug Administration, which has regulatory authority over biomedical interventions and health products, as well as food and additives.